Novavax Inc. planned insider sales
In the last twelve months insiders at Novavax Inc. filed 2 Form 144 notices of planned sales, 51,383 shares worth $531,495 at the time of filing, from 1 seller. The latest, filed 27 May 2026: Ruxandra Draghia Akli (former officer), 21,383 shares worth $235,412, planned for around 27 May 2026 through Merrill Lynch.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Sold, per Form 4 | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 27 May 2026 | Ruxandra Draghia Akli | Former Officer | 21,383 | $235,412 | 27 May 2026 | No matching Form 4 sale | Merrill Lynch | Stock Plan Activity | Form 144 |
| 7 May 2026 | Ruxandra Draghia Akli | Former Officer | 30,000 | $296,083 | 7 May 2026 | No matching Form 4 sale | Merrill Lynch | Stock Plan Activity | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.